摘要 : Lenvatinib is an oral, multi-targeted tyrosine kinase inhibitor of vascular endothelial growth factor receptors 1-3, fibroblast growth factor receptors 1-4, platelet-derived growth factor receptor beta, RET and KIT. Cellular immun... 展开
作者 | Cai~ Chengkuan Tang~ Jingyuan Shen~ Baixin Ding~ Liucheng Shao~ Yunpeng Chen~ Zhengsen Ma~ Yinchao Xue~ Haoliang Wei~ Zhongqing |
---|---|
作者单位 | |
期刊名称 | 《Experimental and therapeutic medicine》 |
总页数 | 8 |
语种/中图分类号 | 英语 / R45 |
关键词 | lenvatinib cellular immunotherapy rat uterine cancer adenocarcinoma-sensitized lymphocyte renal cell carcinoma antitumor |
馆藏号 | N2013EPST0000463 |